BETSY DODSON: Open Payments
NPI 1912988999 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$33,778 in 166 payments from 20 companies in 2025. Trend: 2023 $2,827 · 2024 $64,079 · 2025 $33,778
Speaker / faculty: $22,960Travel & lodging: $6,461Food & beverage: $4,357
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 77 | $31,357 |
| ABBVIE INC. | 31 | $865 |
| Janssen Biotech, Inc. | 16 | $463 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $200 |
| Janssen Scientific Affairs, LLC | 1 | $129 |
| PFIZER INC. | 4 | $121 |
| Braintree Laboratories, Inc. | 3 | $119 |
| Ipsen Biopharmaceuticals, Inc | 3 | $93 |
| Aimmune Therapeutics, Inc. | 3 | $53 |
| Ardelyx, Inc. | 3 | $49 |
Products named: VOQUEZNA, TREMFYA, RINVOQ, SKYRIZI, VELSIPITY, SUFLAVE, ENTYVIO, IQIRVO.
Industry payments across TX — which companies pay providers there.
